World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
144
Citations
83735
World Ranking
1435
National Ranking
837

Overview

Michael G. Shlipak is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the field of medicine, with a strong focus on nephrology, cardiology and cardiovascular medicine, pulmonary and respiratory medicine, physiology, and endocrinology, diabetes, and metabolism.

The main topics addressed in their work include chronic kidney disease and diabetes, dialysis and renal disease management, blood pressure and hypertension studies, acute kidney injury research, heart failure treatment and management, diabetes treatment and management, and renal diseases and glomerulopathies.

Shlipak has contributed to several key publications, with recent notable papers including:

  • KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024), Kidney International
  • Development and Validation of the American Heart Association's PREVENT Equations (2023), Circulation
  • The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2020), Kidney International
  • Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes (2023), JAMA
  • The Promise of Tubule Biomarkers in Kidney Disease: A Review (2021), American Journal of Kidney Diseases

Frequent co-authors in Shlipak's research include Joachim H. Ix, Michelle M. Estrella, Ronit Katz, Rebecca Scherzer, and Orlando M. Gutiérrez.

The scientist's publications frequently appear in prominent venues such as the Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Kidney Medicine, Clinical Journal of the American Society of Nephrology, and Kidney360.

Best Publications

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease

    A Levin;PE Stevens;RW Bilous;J Coresh

  • Cystatin C and the risk of death and cardiovascular events among elderly persons.

    Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried

  • Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis

    Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg

  • Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis

    Grace L. Smith;Judith H. Lichtman;Michael B. Bracken;Michael G. Shlipak;Michael G. Shlipak

  • New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

    Lesley A Inker;Nwamaka D Eneanya;Josef Coresh;Hocine Tighiouart

  • Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency

    Michael G. Shlipak;Linda F. Fried;Casey Crump;Anthony J. Bleyer

  • Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

    John G. Canto;Michael G. Shlipak;William J. Rogers;Judith A. Malmgren

  • Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

    Jacqueline Neuhaus;David R. Jacobs;Jason V. Baker;Jason V. Baker;Alexandra Calmy

  • Cystatin C versus creatinine in determining risk based on kidney function.

    Michael G. Shlipak;Kunihiro Matsushita;Johan Ärnlöv;Johan Ärnlöv;Lesley A. Inker

  • New loci associated with kidney function and chronic kidney disease

    Anna Köttgen;Anna Köttgen;Cristian Pattaro;Carsten A. Böger;Christian Fuchsberger

  • Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors

    Michael G. Shlipak;Linda F. Fried;Mary Cushman;Teri A. Manolio

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

    Kunihiro Matsushita;Josef Coresh;Yingying Sang;John Chalmers

  • Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

    Michael G. Shlipak;Ronit Katz;Mark J. Sarnak;Linda F. Fried

  • Multiple loci associated with indices of renal function and chronic kidney disease

    Anna Köttgen;Nicole L. Glazer;Abbas Dehghan;Shih Jen Hwang

  • Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

    Michael G. Shlipak;Paul A. Heidenreich;Haruko Noguchi;Glenn M. Chertow

  • Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study

    Alan S. Go;Jingrong Yang;Lynn M. Ackerson;Krista Lepper

  • Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

    Linda F. Fried;Michael G. Shlipak;Michael G. Shlipak;Casey Crump;Richard A. Kronmal

  • Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors

    M.G. Shlipak;L.F. Fried;M. Cushman

  • Cystatin C and the Risk of Death and Cardiovascular Events Among Elderly Persons

    M.G. Shilpak;M.J. Sarnak;R. Katz

Frequent Co-Authors

Joachim H. Ix
Joachim H. Ix University of California, San Diego
Ronit Katz
Ronit Katz University of Washington
Mark J. Sarnak
Mark J. Sarnak Tufts Medical Center
Carmen A. Peralta
Carmen A. Peralta University of California, San Francisco
David S. Siscovick
David S. Siscovick University of Washington
Linda F. Fried
Linda F. Fried University of Pittsburgh
Chirag R. Parikh
Chirag R. Parikh Johns Hopkins University
Anne B. Newman
Anne B. Newman University of Pittsburgh
Carl Grunfeld
Carl Grunfeld University of California, San Francisco
Bryan Kestenbaum
Bryan Kestenbaum University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA but are looking for flexible alternatives, online health-related degrees offer diverse career pathways. Many students seek practical programs that help them rapidly enter the workforce or advance their careers, especially through online or accelerated learning options.

For those interested in nursing, a 6 month lpn program can be a quick and efficient route to becoming a licensed practical nurse. If you want to specialize further, the fastest psychiatric nurse practitioner program can provide advanced training in mental health in less time than traditional degrees.

For working professionals, a dnp program without clinical hours may offer the flexibility needed to earn a Doctor of Nursing Practice without the demands of on-site clinical placements. Meanwhile, those interested in the managerial side of healthcare may want to consider a healthcare administration degree online, an affordable option that leads to leadership roles in healthcare organizations.

Best Scientists Citing Michael G. Shlipak

Trending Scientists